2-178451030-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001316362.2(PRKRA):c.-449A>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 1,336,412 control chromosomes in the GnomAD database, including 6,399 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.047 ( 0 hom., cov: 34)
Exomes 𝑓: 0.13 ( 6399 hom. )
Consequence
PRKRA
NM_001316362.2 5_prime_UTR_premature_start_codon_gain
NM_001316362.2 5_prime_UTR_premature_start_codon_gain
Scores
4
2
10
Clinical Significance
Conservation
PhyloP100: 0.533
Genes affected
PRKRA (HGNC:9438): (protein activator of interferon induced protein kinase EIF2AK2) This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0021001399).
BP6
Variant 2-178451030-T-G is Benign according to our data. Variant chr2-178451030-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 332635.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178451030-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0584 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKRA | NM_003690.5 | c.1A>C | p.Met1? | initiator_codon_variant | 1/8 | ENST00000325748.9 | NP_003681.1 | |
PRKRA | NM_001316362.2 | c.-449A>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/9 | NP_001303291.1 | |||
PRKRA | XM_047446138.1 | c.1A>C | p.Met1? | initiator_codon_variant | 1/6 | XP_047302094.1 | ||
PRKRA | NM_001316362.2 | c.-449A>C | 5_prime_UTR_variant | 1/9 | NP_001303291.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKRA | ENST00000325748.9 | c.1A>C | p.Met1? | initiator_codon_variant | 1/8 | 1 | NM_003690.5 | ENSP00000318176.4 |
Frequencies
GnomAD3 genomes AF: 0.0474 AC: 5848AN: 123394Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
5848
AN:
123394
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.257 AC: 41222AN: 160416Hom.: 6543 AF XY: 0.255 AC XY: 22426AN XY: 87862
GnomAD3 exomes
AF:
AC:
41222
AN:
160416
Hom.:
AF XY:
AC XY:
22426
AN XY:
87862
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.134 AC: 162052AN: 1212914Hom.: 6399 Cov.: 38 AF XY: 0.134 AC XY: 80350AN XY: 601090
GnomAD4 exome
AF:
AC:
162052
AN:
1212914
Hom.:
Cov.:
38
AF XY:
AC XY:
80350
AN XY:
601090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0474 AC: 5851AN: 123498Hom.: 0 Cov.: 34 AF XY: 0.0461 AC XY: 2786AN XY: 60438
GnomAD4 genome
AF:
AC:
5851
AN:
123498
Hom.:
Cov.:
34
AF XY:
AC XY:
2786
AN XY:
60438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
31303
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Dystonia 16 Benign:3
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 09, 2020 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 354/2178=16.25% - |
Hearing loss, autosomal recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Dystonic disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Loss of catalytic residue at M1 (P = 0.0205);
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at